NCT00660543View on ClinicalTrials.gov

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Adult Brain Glioblastoma
Interventions
DRUG

Gadolinium

Given IV

DRUG

Ferumoxytol Non-Stoichiometric Magnetite

Given IV

OTHER

Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Undergo DCE MRI

OTHER

Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging

Undergo DSC MRI

OTHER

Diffusion Weighted Imaging

Undergo DWI

OTHER

MRI-Based Angiogram

Undergo TOF MR angiography

Trial Locations (1)

97239

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

OHSU Knight Cancer Institute

OTHER

NCT00660543 - MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy | Biotech Hunter | Biotech Hunter